Cost-effectiveness model to evaluate 200-day vs 100-day treatment with valganciclovir prophylaxis to reduce cytomegalovirus disease in high-risk (d-/r-) kidney transplant recipient in Spain
Servizos
Servizos
Data de publicación
2011Título da revista
Value in Health
Tipo de contido
Publicación de congreso
